SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells.

SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells. Struktur
CAS-Nr.
Englisch Name:
SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells.
Synonyma:
SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells.
CBNumber:
CB65777141
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells. Eigenschaften

Sicherheit

SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells. Chemische Eigenschaften,Einsatz,Produktion Methoden

SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells. Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells. Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou Yuxin Biotechnology Co., Ltd. --
haoxinbio@163.com CHINA 6595 58
Xiamen Huijia Biological Technology Co., Ltd. --
CHINA 6973 58
Xiamen Research Biotechnology Co., Ltd. --
1562893815@qq.com CHINA 6936 58

  • SCR7 is a DNA LIGASE IV inhibitor that can inhibit non-homologous end-joining (NHEJ) of DSBS and induce apoptosis of cancer cells.
Copyright 2019 © ChemicalBook. All rights reserved